Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended clinical study of DSP-1958 (thiotepa) before autologous HSCT
jRCT2080223598Completed
- Sponsor
- Sumitomo Pharma
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of thiotepa in pediatric solid tumors, brain neoplasm and lymphosarcoma (2 arms), sponsored by Sumitomo Pharma. Primary endpoint: Safety of IV thiotepa HDT prior to autologous HSCT. Started Jul 2017; status: completed.
02
Drugs
thiotepa
03
Conditions
pediatric solid tumorsbrain neoplasmlymphosarcoma
Beyond the preview
Go deeper on jRCT2080223598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223598.